GS-2121 is under clinical development by Gilead Sciences and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate (PTSR ...

Adv. Dr. Eyal Bressler will head the patents practice at APM. Following the merger, the intellectual property services that ...

( MENAFN - EIN Presswire) market-grow.png" width="300" height="166" alt="Chronic Hepatitis B market Growth" /> David Correa Allied Market Research +1 800-792-5285 email us here Visit us on social ...

The findings come as debates intensify around the H-1B visa programme, a key route for bringing skilled foreign professionals ...

With cases of Feline Infectious Peritonitis (FIP) on rise in China, cat owners are making their pets pop in Covid-19 drugs as antidotes. But is it safe, and why are they doing so?

Article analyzes Amgen's strong clinical progress and financials, recommending caution due to valuation and technical ...

The US drug administration has approved the use of the medication as an injection for use against the multidrug resistant ...

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory ...

The Triad for Travel Success in 2025 Opinion 0 0 Steve Sitto, Gilead Sciences Global Head of Travel, Meetings & Events 26017 ...

The tolling plan, the first of its kind in the country, appeared to be running smoothly as drivers adjusted to the new fee. See How Much It Will Cost You Why New York Started Congestion Pricing 2 ...

Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...

Kronox Lab Sciences Ltd. share price moved up by 1.24% from its previous close of Rs 199.74. Kronox Lab Sciences Ltd. stock last traded price is 202.21 ...